Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 13-14/2022

07.03.2022 | original article

Elevated serum lead levels in neonates born to mothers suffering from opiate use disorder

verfasst von: Iraj Shahramian, Mahdi Afshari, Fateme Parooie, Morteza Salarzaei, Rezvan Najjari, Mohammad Hasan Mohammadi, MD

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 13-14/2022

Einloggen, um Zugang zu erhalten

Summary

Background

This study was performed to investigate lead levels in neonates born to the mothers suffering from opiate use disorder (OUD) and the association of lead levels with the Apgar score.

Methods

The present cross-sectional study included 56 neonates who were referred to the neonatal ward of Amir-Al Momenin Hospital, Zabol. The neonates were divided into two groups: the neonates whose mothers suffered OUD and the control group. Data were collected using a researcher-prepared questionnaire, and blood lead level was determined using the atomic absorption method. Data were statistically analyzed.

Results

In all, 56 neonates (28 from OUD mothers and 28 from the control mothers) were included in this study. Among the women with OUD, 16 (57%) used inhaled opium, while 12 (43%) consumed opium orally. There was a significant difference regarding Apgar score (9.76 ± 2.11 versus. 7.11 ± 4.21; p = 0.02) and the neonate’s blood lead level (2.33 ± 1.3 µg/dl versus 7.33 ± 5.9 µg/dl) between the control and OUD groups (p < 0.001). The odds ratio of abnormally elevated blood lead level rose with increasing duration of maternal opiate disorder for opiate usage durations of 3 to 5 years (adjusted odds ratio [OR] 42.82, 95% confidence interval [CI] 3.27–561, p = 0.004) and > 5 years (adjusted OR 45.5, 95% CI 2.97–698, p = 0.006).

Conclusion

The results of this study suggested a significant relationship between maternal opium consumption during pregnancy and neonatal serum lead levels, as well as decreased neonatal Apgar score.
Literatur
1.
Zurück zum Zitat Specialists OOTI. Lead and pregnancy. 2009. Specialists OOTI. Lead and pregnancy. 2009.
2.
Zurück zum Zitat Weizsaecker K. Lead toxicity during pregnancy. Prim Care Update Ob Gyns. 2003;10:304–9.CrossRef Weizsaecker K. Lead toxicity during pregnancy. Prim Care Update Ob Gyns. 2003;10:304–9.CrossRef
3.
Zurück zum Zitat Maghsoudlou S, Cnattingius S, Montgomery S, Aarabi M, Semnani S, Wikström AK, et al. Opium use during pregnancy and infant size at birth: a cohort study. BMC Pregnancy Childbirth. 2018;18(1):1–8.CrossRef Maghsoudlou S, Cnattingius S, Montgomery S, Aarabi M, Semnani S, Wikström AK, et al. Opium use during pregnancy and infant size at birth: a cohort study. BMC Pregnancy Childbirth. 2018;18(1):1–8.CrossRef
4.
Zurück zum Zitat Maghsoudlou S, Cnattingius S, Montgomery S, Aarabi M, Semnani S, Wikström AK, et al. Opium use during pregnancy and risk of preterm delivery: A population-based cohort study. PLoS ONE. 2017;12(4):e176588.PubMedPubMedCentralCrossRef Maghsoudlou S, Cnattingius S, Montgomery S, Aarabi M, Semnani S, Wikström AK, et al. Opium use during pregnancy and risk of preterm delivery: A population-based cohort study. PLoS ONE. 2017;12(4):e176588.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Saleh Gargari S, Fallahian M, Haghighi L, Hosseinnezhad-Yazdi M, Dashti E, Dolan K. Maternal and neonatal complications of substance abuse in Iranian pregnant women. Acta Med Iran. 2012;50(6):411–6. PMID: 22837120.PubMed Saleh Gargari S, Fallahian M, Haghighi L, Hosseinnezhad-Yazdi M, Dashti E, Dolan K. Maternal and neonatal complications of substance abuse in Iranian pregnant women. Acta Med Iran. 2012;50(6):411–6. PMID: 22837120.PubMed
6.
8.
Zurück zum Zitat Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and Biomarkers of lead exposure: a review. Rev Environ Health. 2009;24:15.PubMedPubMedCentralCrossRef Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and Biomarkers of lead exposure: a review. Rev Environ Health. 2009;24:15.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Xu J, Yan HC, Yang B, Tong LS, Zou YX, Tian Y. Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats. J Negat Results BioMed. 2009;8:1–8.CrossRef Xu J, Yan HC, Yang B, Tong LS, Zou YX, Tian Y. Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats. J Negat Results BioMed. 2009;8:1–8.CrossRef
10.
Zurück zum Zitat Friberg L, Nordberg GF, Vouk VB. Handbook on the toxicology of metals. Jan van Galenstraat: Elsevier/North-Holland Biomedical Press; 1979. p. 335. 1061 AZ. Friberg L, Nordberg GF, Vouk VB. Handbook on the toxicology of metals. Jan van Galenstraat: Elsevier/North-Holland Biomedical Press; 1979. p. 335. 1061 AZ.
11.
Zurück zum Zitat Raghunath R, Tripathi R, Khandekar R, Nambi K. Retention times of Pb, cd, Cu and zn in children’s blood. Sci Total Environ. 1997;207:133–9.PubMedCrossRef Raghunath R, Tripathi R, Khandekar R, Nambi K. Retention times of Pb, cd, Cu and zn in children’s blood. Sci Total Environ. 1997;207:133–9.PubMedCrossRef
12.
Zurück zum Zitat Ferrer E, AlegríA A, Barberá R, Farré R, Lagarda MJ, Monleon J. Whole blood selenium content in pregnant women. Sci Total Environ. 1999;227:139–43.PubMedCrossRef Ferrer E, AlegríA A, Barberá R, Farré R, Lagarda MJ, Monleon J. Whole blood selenium content in pregnant women. Sci Total Environ. 1999;227:139–43.PubMedCrossRef
13.
Zurück zum Zitat Gathwala G, Yadav O, Singh I, Sangwan K. Maternal and cord plasma selenium levels in full term neonates. Indian J Pediatr. 2000;67:729–31.PubMedCrossRef Gathwala G, Yadav O, Singh I, Sangwan K. Maternal and cord plasma selenium levels in full term neonates. Indian J Pediatr. 2000;67:729–31.PubMedCrossRef
14.
Zurück zum Zitat Gulson B, Jameson C, Mahaffey K, Mizon K, Korsch M, Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med. 1997;130:51–62.PubMedCrossRef Gulson B, Jameson C, Mahaffey K, Mizon K, Korsch M, Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med. 1997;130:51–62.PubMedCrossRef
15.
Zurück zum Zitat Bellinger DC. Very low lead exposures and children’s neurodevelopment. Curr Opin Pediatr. 2008;20:172–7.PubMedCrossRef Bellinger DC. Very low lead exposures and children’s neurodevelopment. Curr Opin Pediatr. 2008;20:172–7.PubMedCrossRef
16.
Zurück zum Zitat Meyer PA, Mcgeehin MA, Falk H. A global approach to childhood lead poisoning prevention. Int J Hyg Environ Health. 2003;206:363–9.PubMedCrossRef Meyer PA, Mcgeehin MA, Falk H. A global approach to childhood lead poisoning prevention. Int J Hyg Environ Health. 2003;206:363–9.PubMedCrossRef
17.
Zurück zum Zitat Gomaa A, Hu H, Bellinger D, Schwartz J, Tsaih S‑W, Gonzalez-Cossio T, et al. Maternal Bone lead as an independent risk factor for fetal neurotoxicity: a prospective study. Pediatrics. 2002;110:110–8.PubMedCrossRef Gomaa A, Hu H, Bellinger D, Schwartz J, Tsaih S‑W, Gonzalez-Cossio T, et al. Maternal Bone lead as an independent risk factor for fetal neurotoxicity: a prospective study. Pediatrics. 2002;110:110–8.PubMedCrossRef
18.
Zurück zum Zitat Dharmanada S. Lead content of soil, plants, foods, air, and Chinese herb formulas. 2010. Dharmanada S. Lead content of soil, plants, foods, air, and Chinese herb formulas. 2010.
19.
Zurück zum Zitat Jones EA, Wright JM, Rice G, Buckley BT, Magsumbol MS, Barr DB, et al. Metal exposures in an inner-city neonatal population. Environ Int. 2010;36:649–54.PubMedCrossRef Jones EA, Wright JM, Rice G, Buckley BT, Magsumbol MS, Barr DB, et al. Metal exposures in an inner-city neonatal population. Environ Int. 2010;36:649–54.PubMedCrossRef
20.
Zurück zum Zitat Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 Μg per deciliter. N Engl J Med. 2003;348:1517–26.PubMedPubMedCentralCrossRef Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 Μg per deciliter. N Engl J Med. 2003;348:1517–26.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Satin KP, Neutra RR, Guirguis G, Flessel P. Umbilical cord blood lead levels in California. Arch Environ Heal Int J. 1991;46:167–73.CrossRef Satin KP, Neutra RR, Guirguis G, Flessel P. Umbilical cord blood lead levels in California. Arch Environ Heal Int J. 1991;46:167–73.CrossRef
22.
Zurück zum Zitat Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas county, Florida. N Engl J Med. 1990;322:1202–6.PubMedCrossRef Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas county, Florida. N Engl J Med. 1990;322:1202–6.PubMedCrossRef
23.
Zurück zum Zitat Chasnoff IJ, Mcgourty RF, Bailey GW, Hutchins E, Lightfoot SO, Pawson LL, et al. The 4p’s plus© screen for substance use in pregnancy: clinical application and outcomes. J Perinatol. 2005;25:368–74.PubMedCrossRef Chasnoff IJ, Mcgourty RF, Bailey GW, Hutchins E, Lightfoot SO, Pawson LL, et al. The 4p’s plus© screen for substance use in pregnancy: clinical application and outcomes. J Perinatol. 2005;25:368–74.PubMedCrossRef
24.
Zurück zum Zitat D’alessandro Gandolfo L, Macri A, Biolcati G, Rossi F, Cirelli A, Barlattani A, et al. An unusual mechanism of lead poisoning. Presentation of a case. Recenti Prog Med. 1989;80:140–1.PubMed D’alessandro Gandolfo L, Macri A, Biolcati G, Rossi F, Cirelli A, Barlattani A, et al. An unusual mechanism of lead poisoning. Presentation of a case. Recenti Prog Med. 1989;80:140–1.PubMed
25.
Zurück zum Zitat Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996–1998. Obstet Gynecol. 2003;101:374–9.PubMed Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996–1998. Obstet Gynecol. 2003;101:374–9.PubMed
26.
Zurück zum Zitat Masoudi M, Zali MR, Ehsani M, Mohammadalizadeh A‑H, Aiassofi K, Aghazadeh R, et al. Abdominal pain Due to lead-contaminated opium: a new source of inorganic lead poisoning in Iran. 2006. Masoudi M, Zali MR, Ehsani M, Mohammadalizadeh A‑H, Aiassofi K, Aghazadeh R, et al. Abdominal pain Due to lead-contaminated opium: a new source of inorganic lead poisoning in Iran. 2006.
27.
Zurück zum Zitat Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med. 1993;329:850–4.PubMedCrossRef Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med. 1993;329:850–4.PubMedCrossRef
28.
Zurück zum Zitat Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382–94.PubMedCrossRef Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382–94.PubMedCrossRef
29.
Zurück zum Zitat Ghasempouri S, Hatami M, Zakariaei Z, Khosravi N, Khadir M. Lead poisoning in opium abusers: a five-year retrospective study. J Mazandaran Univ Med Sci. 2019;29(179):169–73. Ghasempouri S, Hatami M, Zakariaei Z, Khosravi N, Khadir M. Lead poisoning in opium abusers: a five-year retrospective study. J Mazandaran Univ Med Sci. 2019;29(179):169–73.
30.
Zurück zum Zitat Zamani N, Mehrpour O, Hassanian-Moghaddam H, Jalali M, Amirabadizadeh A, Samie S, et al. A preliminary report on the largest ongoing outbreak of lead toxicity in Iran. Sci Rep. 2020;10(1):1–7.CrossRef Zamani N, Mehrpour O, Hassanian-Moghaddam H, Jalali M, Amirabadizadeh A, Samie S, et al. A preliminary report on the largest ongoing outbreak of lead toxicity in Iran. Sci Rep. 2020;10(1):1–7.CrossRef
31.
Zurück zum Zitat Rezaie M, Abolhassanzadeh SZ, Haghighinejad H. Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017–2018. J Family Med Prim Care. 2019;8(5):1653.PubMedPubMedCentralCrossRef Rezaie M, Abolhassanzadeh SZ, Haghighinejad H. Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017–2018. J Family Med Prim Care. 2019;8(5):1653.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Hatami G, Eghbali S, Darki A. Evaluation of serum lead levels in 6–7 year old children in Bushehr in 2012. South Med. 2019;21:459–71. Hatami G, Eghbali S, Darki A. Evaluation of serum lead levels in 6–7 year old children in Bushehr in 2012. South Med. 2019;21:459–71.
33.
Zurück zum Zitat Maleknejad S, Heidarzadeh A, Rahbar M, Safaei A, Ghomashpasand B. Evaluation of serum lead levels in children with constipation and normal controls in northern Iran. Iran J Pediatr. 2013;23:417.PubMedPubMedCentral Maleknejad S, Heidarzadeh A, Rahbar M, Safaei A, Ghomashpasand B. Evaluation of serum lead levels in children with constipation and normal controls in northern Iran. Iran J Pediatr. 2013;23:417.PubMedPubMedCentral
34.
Zurück zum Zitat Olivero-Verbel J, Duarte D, Echenique M, Guette J, Johnson-Restrepo B, Parsons PJ. Blood lead levels in children aged 5–9 years living in Cartagena, Colombia. Sci Total Environ. 2007;372:707–16.PubMedCrossRef Olivero-Verbel J, Duarte D, Echenique M, Guette J, Johnson-Restrepo B, Parsons PJ. Blood lead levels in children aged 5–9 years living in Cartagena, Colombia. Sci Total Environ. 2007;372:707–16.PubMedCrossRef
36.
Zurück zum Zitat Khanna MM. Boys, not girls, are negatively affected on cognitive tasks by lead exposure: a pilot study. J Environ Health. 2015;77:72–7.PubMed Khanna MM. Boys, not girls, are negatively affected on cognitive tasks by lead exposure: a pilot study. J Environ Health. 2015;77:72–7.PubMed
38.
Zurück zum Zitat Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, et al. Trends in blood lead levels and blood lead testing among us children aged 1 to 5 years, 1988–2004. Pediatrics. 2009;123:e376–e85.PubMedCrossRef Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, et al. Trends in blood lead levels and blood lead testing among us children aged 1 to 5 years, 1988–2004. Pediatrics. 2009;123:e376–e85.PubMedCrossRef
39.
Zurück zum Zitat Shah-Kulkarni S, Lee S, Jeong KS, Hong YC, Park H, Ha M, et al. Prenatal exposure to mixtures of heavy metals and neurodevelopment in infants at 6 months. Environ Res. 2020;182:109122.PubMedCrossRef Shah-Kulkarni S, Lee S, Jeong KS, Hong YC, Park H, Ha M, et al. Prenatal exposure to mixtures of heavy metals and neurodevelopment in infants at 6 months. Environ Res. 2020;182:109122.PubMedCrossRef
40.
Zurück zum Zitat Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology. 2015;40(1):61–87.PubMedCrossRef Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology. 2015;40(1):61–87.PubMedCrossRef
41.
Zurück zum Zitat Minnes S, Lang A, Singer L. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Addict Sci Clin Pract. 2011;6(1):57.PubMedPubMedCentral Minnes S, Lang A, Singer L. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Addict Sci Clin Pract. 2011;6(1):57.PubMedPubMedCentral
42.
Zurück zum Zitat Yeoh SL, Eastwood J, Wright IM, Morton R, Melhuish E, Ward M, et al. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(7):e197025.PubMedPubMedCentralCrossRef Yeoh SL, Eastwood J, Wright IM, Morton R, Melhuish E, Ward M, et al. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(7):e197025.PubMedPubMedCentralCrossRef
Metadaten
Titel
Elevated serum lead levels in neonates born to mothers suffering from opiate use disorder
verfasst von
Iraj Shahramian
Mahdi Afshari
Fateme Parooie
Morteza Salarzaei
Rezvan Najjari
Mohammad Hasan Mohammadi, MD
Publikationsdatum
07.03.2022
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 13-14/2022
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-022-00922-5

Weitere Artikel der Ausgabe 13-14/2022

Wiener Medizinische Wochenschrift 13-14/2022 Zur Ausgabe